Artificial Intelligence in IVD Market Growth, Size, Trends Analysis - By Application, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033
Artificial Intelligence in IVD Market Introduction and Overview
According to SPER market research, ‘Global Artificial Intelligence in IVD Market Size- By Application, By Technology, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Artificial Intelligence in IVD Market is predicted to reach 2.62 billion by 2033 with a CAGR of 22.6%.
The application of machine learning and computational algorithms to the analysis and interpretation of diagnostic data is known as artificial intelligence (AI) in in-vitro diagnostics (IVD). This is done to enhance clinical decision-making, accuracy, and efficiency in laboratory testing and medical diagnostics. Diabetes, heart disease, and cancer are among the chronic illnesses that are becoming more prevalent globally. AI is being used more and more to enhance the effectiveness, accuracy, and customized treatment options for a range of illnesses.
The Covid-19 epidemic has highlighted the value of artificial intelligence (AI) in in vitro diagnostics, particularly in domains such as medical imaging and clinical decision support. AI technology have helped in the identification and management of Covid-19 patients, allowing for the quick analysis of chest X-rays and CT scans to detect lung abnormalities. AI has also aided the creation of predictive models and risk assessment tools to help healthcare providers manage the epidemic.
Scope of the report:
Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Application, By Technology, By End User
Regions covered
North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered
Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Danaher Corporation (Beckman Coulter), Sysmex Corporation, BioMerieux, Shenzhen Mindray Bio-Medical Electronics Co, Cardinal Health, PerkinElmer.
Artificial Intelligence in IVD Market Segmentation:
By Application: Based on the Application, Global Artificial Intelligence in IVD Market is segmented as; Oncology, Infectious Disease, Cardiology, Other Applications.
By Technology: Based on the Technology, Global Artificial Intelligence in IVD Market is segmented as; Machine Learning, Deep Learning, Other Technologies.
By End User: Based on the End User, Global Artificial Intelligence in IVD Market is segmented as; Hospitals and Clinics, Diagnostic Laboratories, Other End Users.
By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER’s internal database
- 2.1.4. Premium insight from KOL’s
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impacts of the Global Artificial Intelligence in IVD Market.
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER’s Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global Artificial Intelligence in IVD Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Artificial Intelligence in IVD Market
- 7. Global Artificial Intelligence in IVD Market, By Application (USD Million) 2020-2033
- 7.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Application, 2020-2026
- 7.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Application, 2027-2033
- 7.3. Oncology
- 7.4. Infectious Disease
- 7.5. Cardiology
- 7.6. Other Applications
- 8. Global Artificial Intelligence in IVD Market, By Technology (USD Million) 2020-2033
- 8.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Technology, 2020-2026
- 8.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Technology, 2027-2033
- 8.3. Machine Learning
- 8.4. Deep Learning
- 8.5. Other Technologies
- 9. Global Artificial Intelligence in IVD Market, By End User (USD Million) 2020-2033
- 9.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By End User, 2020-2026
- 9.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By End User, 2027-2033
- 9.3. Hospitals and Clinics
- 9.4. Diagnostic Laboratories
- 9.5. Other End Users
- 10. Global Artificial Intelligence in IVD Market Forecast, 2020-2033 (USD Million)
- 10.1. Global Artificial Intelligence in IVD Market Size and Market Share
- 11. Global Artificial Intelligence in IVD Market, By Region, 2020-2033 (USD Million)
- 11.1. Global Artificial Intelligence in IVD Market Size and Market Share By Region (2020-2026)
- 11.2. Global Artificial Intelligence in IVD Market Size and Market Share By Region (2027-2033)
- 11.3. Asia-Pacific
- 11.3.1. Australia
- 11.3.2. China
- 11.3.3. India
- 11.3.4. Japan
- 11.3.5. South Korea
- 11.3.6. Rest of Asia-Pacific
- 11.4. Europe
- 11.4.1. France
- 11.4.2. Germany
- 11.4.3. Italy
- 11.4.4. Spain
- 11.4.5. United Kingdom
- 11.4.6. Rest of Europe
- 11.5. Middle East and Africa
- 11.5.1. Kingdom of Saudi Arabia
- 11.5.2. United Arab Emirates
- 11.5.3. Qatar
- 11.5.4. South Africa
- 11.5.5. Egypt
- 11.5.6. Morocco
- 11.5.7. Nigeria
- 11.5.8. Rest of Middle-East and Africa
- 11.6. North America
- 11.6.1. Canada
- 11.6.2. Mexico
- 11.6.3. United States
- 11.7. Latin America
- 11.7.1. Argentina
- 11.7.2. Brazil
- 11.7.3. Rest of Latin America
- 12. Company Profile
- 12.1. Abbott
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. F. Hoffmann-La Roche Ltd
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Siemens Healthineers AG
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Thermo Fisher Scientific Inc
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. Danaher Corporation
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Sysmex Corporation
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. BioMerieux
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Shenzhen Mindray Bio-Medical Electronics Co
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Cardinal Health
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. PerkinElmer
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Others
- 13. Conclusion
- 14. List of Abbreviations
- 15. Reference Links
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook